Clinical Trials Logo

Anal Cancer Patients clinical trials

View clinical trials related to Anal Cancer Patients.

Filter by:
  • None
  • Page 1

NCT ID: NCT06364579 Recruiting - Clinical trials for Anal Cancer Patients

Patient Reported Outcomes (PROs) in Anal Cancer Patient Treated by Intensity Modulated Radiotherapy (IMRT).

PROACT
Start date: March 28, 2024
Phase:
Study type: Observational

Radiochemotherapy is the standard treatment for neoplasms of the anal canal with excellent rates of local control and preservation of the anal sphincter. However, patients may experience a deterioration of quality of life related to sequelae of the treatment particularly at intestinal, anal sphincter and sexual level. Few studies to date have documented patient-reported outcomes (PROs) in this area. The aim of this observational study is to verify the quality of life (QOL) of the patients by means of self-completed questionnaires.

NCT ID: NCT01053923 Withdrawn - Clinical trials for Anal Cancer Patients

MRI for Tumor During Chemoradiation for Anal Canal and Perianal Cancer

Start date: December 2009
Phase: N/A
Study type: Observational

The purpose of this study is to establish a prospective database of anal canal and perianal cancer patients treated with IMRT and chemotherapy with curative intent at PMH for the purposes of investigating MRI-derived primary tumor parameters. Patients who decide to participate in this study will be treated according to standard treatment policies and radiation therapy planning protocols at Princess Margaret Hospital (PMH) with radiation therapy +/- chemotherapy. IMRT for all treatment phases of radiotherapy has been implemented as standard treatment. Surgery is reserved for salvage treatment.